Abstract
Several diseases of the airways have a strong component of allergic inflammation in their cause, including allergic rhinitis, asthma, polypoid chronic rhinosinusitis, eosinophilic bronchitis, and others. Although the roles played by antigens and pathogens vary, these diseases have in common a pathology that includes marked activation of epithelial cells in the upper airways, the lower airways, or both. Substantial new evidence indicates an important role of epithelial cells as both mediators and regulators of innate immune responses and adaptive immune responses, as well as the transition from innate immunity to adaptive immunity. The purpose of this review is to discuss recent studies that bear on the molecular and cellular mechanisms by which epithelial cells help to shape the responses of dendritic cells, T cells, and B cells and inflammatory cell recruitment in the context of human disease. Evidence will be discussed that suggests that secreted products of epithelial cells and molecules expressed on their cell surfaces can profoundly influence both immunity and inflammation in the airways.
Original language | English (US) |
---|---|
Pages (from-to) | 1279-1284 |
Number of pages | 6 |
Journal | Journal of Allergy and Clinical Immunology |
Volume | 120 |
Issue number | 6 |
DOIs | |
State | Published - Dec 2007 |
Funding
Disclosure of potential conflict of interest: R. P. Schleimer has received grant support from the National Institutes of Health and has served as an expert witness in patent infringement cases. P. C. Avila has consulting arrangements with Genentech and has received grant support from Genentech, Novartis, GlaxoSmithKline, AstraZeneca, and Aventis. The rest of the authors have declared that they have no conflict of interest.
Keywords
- Epithelium
- adaptive immunity
- airway inflammation
- immune regulation
- innate immunity
ASJC Scopus subject areas
- Immunology and Allergy
- Immunology